1-benzoyl-4-[[[(5-methylpyridin-2-yl)methyl]amino]methyl]-piperidin-4-ol | 1250831-52-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-benzoyl-4-[[[(5-methylpyridin-2-yl)methyl]amino]methyl]-piperidin-4-ol
• 英文别名: [4-Hydroxy-4-[[(5-methylpyridin-2-yl)methylamino]methyl]piperidin-1-yl]-phenylmethanone
• CAS: 1250831-52-7
• 化学式: C₂₀H₂₅N₃O₂
• 分子量: 339.437
• InChiKey: ZPXBRCNWTOBYAX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  25
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  65.5
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-benzoyl-4-[[[(5-methylpyridin-2-yl)methyl]amino]methyl]-piperidin-4-ol 在 盐酸 、 水 作用下， 反应 15.0h， 以80%的产率得到4-[[[(5-methylpyridin-2-yl)methyl]amino]methyl]piperidin-4-ol trihydrochloride
  参考文献：
  名称：

  Novel Pyridylmethylamines as Highly Selective 5-HT_1A Superagonists

  摘要：

  To further improve the maximal serotonergic efficacy and better understand the configurational requirements for 5-HT1A binding and activation, we generated and biologically investigated structural variants of the lead structure befiradol. For a bioisosteric replacement of the 3-chloro-4-fluoro moiety, a focused library of 63 compounds by solution phase parallel synthesis was developed. Target binding of our compound collection was investigated, and their affinities for 5-HT2, alpha(1), and alpha(2)-adrenergic as well as D-1-D-4 at dopamine receptors were compared. For particularly interesting test compounds, intrinsic activities at 5-HT1A were examined in vitro employing a GTP gamma S assay. The investigation guided as to highly selective 5HT(1A) superagonists. The benzothiophene-3-carboxamide 8bt revealed almost exclusive 5HT(1A) recognition with a K-i value of 2.7 nM and a maximal efficacy of 124%. To get insights into the bioactive conformation of our compound collection, we synthesized conformationally constrained bicyclic scaffolds when SAR data indicated a chair-type geometry and an equatorially dispositioned aminomethyl substituent for the 4,4-disubstituted piperidine moiety.

  DOI：

  10.1021/jm100835q
• 作为产物：
  描述：

  5-甲基吡啶-2-甲醛 、 4-(aminomethyl)-1-benzoylpiperidin-4-ol 在 sodium cyanoborohydride 作用下， 以 甲醇 为溶剂， 反应 16.0h， 以52%的产率得到1-benzoyl-4-[[[(5-methylpyridin-2-yl)methyl]amino]methyl]-piperidin-4-ol
  参考文献：
  名称：

  Novel Pyridylmethylamines as Highly Selective 5-HT_1A Superagonists

  摘要：

  To further improve the maximal serotonergic efficacy and better understand the configurational requirements for 5-HT1A binding and activation, we generated and biologically investigated structural variants of the lead structure befiradol. For a bioisosteric replacement of the 3-chloro-4-fluoro moiety, a focused library of 63 compounds by solution phase parallel synthesis was developed. Target binding of our compound collection was investigated, and their affinities for 5-HT2, alpha(1), and alpha(2)-adrenergic as well as D-1-D-4 at dopamine receptors were compared. For particularly interesting test compounds, intrinsic activities at 5-HT1A were examined in vitro employing a GTP gamma S assay. The investigation guided as to highly selective 5HT(1A) superagonists. The benzothiophene-3-carboxamide 8bt revealed almost exclusive 5HT(1A) recognition with a K-i value of 2.7 nM and a maximal efficacy of 124%. To get insights into the bioactive conformation of our compound collection, we synthesized conformationally constrained bicyclic scaffolds when SAR data indicated a chair-type geometry and an equatorially dispositioned aminomethyl substituent for the 4,4-disubstituted piperidine moiety.

  DOI：

  10.1021/jm100835q

文献信息

• Novel Pyridylmethylamines as Highly Selective 5-HT_1A Superagonists
  作者：Stefan Bollinger、Harald Hübner、Frank W. Heinemann、Karsten Meyer、Peter Gmeiner

  DOI：10.1021/jm100835q

  日期：2010.10.14

  To further improve the maximal serotonergic efficacy and better understand the configurational requirements for 5-HT1A binding and activation, we generated and biologically investigated structural variants of the lead structure befiradol. For a bioisosteric replacement of the 3-chloro-4-fluoro moiety, a focused library of 63 compounds by solution phase parallel synthesis was developed. Target binding of our compound collection was investigated, and their affinities for 5-HT2, alpha(1), and alpha(2)-adrenergic as well as D-1-D-4 at dopamine receptors were compared. For particularly interesting test compounds, intrinsic activities at 5-HT1A were examined in vitro employing a GTP gamma S assay. The investigation guided as to highly selective 5HT(1A) superagonists. The benzothiophene-3-carboxamide 8bt revealed almost exclusive 5HT(1A) recognition with a K-i value of 2.7 nM and a maximal efficacy of 124%. To get insights into the bioactive conformation of our compound collection, we synthesized conformationally constrained bicyclic scaffolds when SAR data indicated a chair-type geometry and an equatorially dispositioned aminomethyl substituent for the 4,4-disubstituted piperidine moiety.